| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000022874 |
| Receipt No. | R000026304 |
| Official scientific title of the study | Safety and feasibility evaluation of the novel arm motion measurement device evaluatio for central nerve disorder patients |
| Date of disclosure of the study information | 2016/07/01 |
| Last modified on | 2016/06/24 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | Safety and feasibility evaluation of the novel arm motion measurement device evaluatio for central nerve disorder patients | |
| Title of the study (Brief title) | Evaluation of the novel upper arm motion measurement device | |
| Region |
|
|
| Condition | |||
| Condition | dysfunction of voluntary movement | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | feasibility, safety |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | /adverse reaction
|
| Key secondary outcomes | |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | /Single time intervention
/Repeat up to 200 times of arm reach movement with a new robot manipulandum. /maximum 1hour |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | /They can perform the reach movement about 10 cm on the horizontal plane desk.
/For around one hour, they can sit down on a chair. |
|||
| Key exclusion criteria | /The condition of their disease is not stable.
/They have cognitive impairment, and cannot understand the task. /In everyday life, there is defect in eyesight of the degree to need consideration for movement to need sight information, field of vision, the space recognition. /A finger has the skin damage. /A finger has an osteoarticular disease. |
|||
| Target sample size | 25 | |||
| Research contact person | |
| Name of lead principal investigator | Tomoyuki Ueno |
| Organization | Department of Rehabilitation, University of Tsukuba Hospital |
| Division name | Department of Rehabilitation |
| Address | 2-1-1, Amakubo, Tsukuba. Ibaraki, Japan |
| TEL | 029-853-3795 |
| uenot@md.tsukuba.ac.jp | |
| Public contact | |
| Name of contact person | Tomoyuki Ueno |
| Organization | Department of Rehabilitation, University of Tsukuba Hospital |
| Division name | Department of Rehabilitation |
| Address | 2-1-1, Amakubo, Tsukuba. Ibaraki, Japan |
| TEL | 029-853-3795 |
| Homepage URL | |
| uenot@md.tsukuba.ac.jp | |
| Sponsor | |
| Institute | University of Tsukuba |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | University of Tsukuba |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000026304 |